Novonix Limited (NVX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Novonix Limited

    NASDAQ: NVX · Real-Time Price · USD
    1.28
    -0.05 (-3.76%)
    At close: Sep 04, 2025, 3:59 PM
    1.28
    0.00%
    Pre-market: Sep 05, 2025, 04:51 AM EDT

    Novonix Income Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Jun 30, 2022
    Revenue
    		 5.85M 12.13M 3.69M 6.1M
    Cost of Revenue
    		 1.77M 2.82M 24.32M 1.72M
    Gross Profit
    		 4.08M 9.32M -20.63M 4.38M
    Operating Income
    		 -51.52M -45.47M -39.08M -47.47M
    Interest Income
    		 1.37M 1.61M 26.54K 8.31K
    Pretax Income
    		 -74.72M -46.45M -38.08M -51.86M
    Net Income
    		 -74.82M -46.25M -38.08M -51.86M
    Selling & General & Admin
    		 49.08M 44.78M 15.69M 39.86M
    Research & Development
    		 4.85M 5.75M 2.76M 5.1M
    Other Expenses
    		 1.68M n/a n/a 605.04K
    Operating Expenses
    		 55.6M 5.24M 18.45M 52.42M
    Interest Expense
    		 3.56M 2.87M 1.29M 1.47M
    Selling & Marketing Expenses
    		 n/a 14.26M -6.1M n/a
    Cost & Expenses
    		 57.37M 53.52M 42.78M 54.14M
    Income Tax Expense
    		 97.69K -199.95K 1.37 2.07M
    Shares Outstanding (Basic)
    		 124.22M 121.87M 121.65M 116.11M
    Shares Outstanding (Diluted)
    		 124.22M 121.87M 121.65M 116.11M
    EPS (Basic)
    		 -0.6 -0.56 -0.3 -0.44
    EPS (Diluted)
    		 -0.6 -0.56 -0.3 -0.44
    EBITDA
    		 -66.61M -38.86M -33.28M -43.26M
    EBIT
    		 -71.18M -43.6M -53.84M -50.39M
    Depreciation & Amortization
    		 4.57M 4.74M 3.52M 4.21M

    Add to Watchlist